Aarti Drugs balance sheet

As of Mar 2026

Total assets: ₹2,815cr+9.3% on Mar 2025
Shareholders' equity: ₹1,549cr+13.1% on Mar 2025
Total debt: ₹575cr−6.1% on Mar 2025
Cash and investments: ₹7.3cr+58.7% on Mar 2025

₹ crore except per share

Tap a line for its trend	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Current assets
Non-current assets					FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	1,068	856	808	675
	214	330	225	210
	16.4	7.2	1.2	0.8
	—	—	35.7	—
	27.3	22.4	20.0	18.8
	—	20.3	—	23.7
	27.3	42.7	20.0	42.5
	21.7	—	21.5	—
	1,347	1,236	1,112	929
	491	473	486	516
	830	751	705	865
	7.3	4.6	6.7	9.0
	1.5	3.0	2.7	0.0
	0.7	0.8	0.2	0.0
	15.5	15.1	11.3	12.2
	855	775	726	886
	122	80.9	109	90.1
	1,468	1,338	1,321	1,492
	2,815	2,575	2,432	2,421
Equity
	91.3	91.3	91.9	92.6
	1,458	1,278	1,190	1,100
	1,549	1,369	1,282	1,192
	0.4	0.3	0.4	0.2
	1,549	1,369	1,282	1,193
Liabilities
	257	284	275	205
	1.1	1.8	1.1	12.8
	258	286	276	218
	4.6	4.3	2.7	7.3
	81.3	78.2	75.7	71.0
	344	368	355	296
	318	328	287	402
	478	416	425	480
	23.8	21.4	27.3	2.0
	820	766	740	884
	8.1	4.3	3.0	4.4
	7.2	0.0	1.2	—
	87.4	66.9	51.6	44.5
	922	837	796	933
	1,266	1,205	1,150	1,229
	2,815	2,575	2,432	2,421
Assets — additional as-filed lines
	0.0	10.0	—	—
Trade payables — MSME split
	24.1	11.8	—	—
	454	404	—	—

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

AARTIDRUGS₹449.00

Aarti Drugs Ltd.

· Pharma & Health

₹ CrorePeersALIVUS AARTIPHARM ADVENZYMES AGARWALEYE AKUMS APLLTD CORONA HCGMcap ₹4,098 Cr

View

In ₹ Crore except Per Share As of	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Non-current Assets
+ Property, Plant & Equipment	675.4	808.2	856.3	1,068.3	1,068.3
+ Capital Work-in-Progress	210.4	225.2	330.2	213.8	213.8
+ Other Intangibles	0.8	1.2	7.2	16.4	16.4
+ Intangibles under Development	—	35.7	—	—	—
+ Non-current Investments	18.8	20.0	22.4	27.3	27.3
+ Other Non-current Financial Assets	23.7	—	20.3	—	—
Non-current Financial Assets	42.5	20.0	42.7	27.3	27.3
+ Other Non-current Assets	—	21.5	—	21.7	21.7
Total Non-current Assets	929.0	1,111.6	1,236.3	1,347.5	1,347.5
Current Assets
+ Inventories	516.3	485.9	472.9	490.8	490.8
+ Trade Receivables	864.8	704.6	751.2	829.9	829.9
+ Cash & Cash Equivalents	9.0	6.7	4.6	7.3	7.3
+ Other Bank Balances	0.0	2.7	3.0	1.5	1.5
+ Short-term Loans	0.0	0.2	0.8	0.7	0.7
+ Other Current Financial Assets	12.2	11.3	15.1	15.5	15.5
Current Financial Assets	886.0	725.6	774.6	854.9	854.9
+ Other Current Assets	90.1	109.3	80.9	122.1	122.1
Total Current Assets	1,492.4	1,320.7	1,338.4	1,467.8	1,467.8
Total Assets	2,421.4	2,432.4	2,574.7	2,815.3	2,815.3
Equity
+ Equity Share Capital	92.6	91.9	91.3	91.3	91.3
+ Other Equity / Reserves	1,099.8	1,189.6	1,277.7	1,457.6	1,457.6
Equity — Owners of Parent	1,192.4	1,281.6	1,369.0	1,548.9	1,548.9
+ Minority Interest	0.2	0.4	0.3	0.4	0.4
Total Equity	1,192.7	1,282.0	1,369.3	1,549.2	1,549.2
Liabilities
+ Borrowings — Non-current	204.7	275.3	284.0	256.9	256.9
+ Other Non-current Financial Liab	12.8	1.1	1.8	1.1	1.1
Non-current Financial Liabilities	217.5	276.4	285.8	258.0	258.0
+ Provisions — Non-current	7.3	2.7	4.3	4.6	4.6
+ Deferred Tax Liabilities	71.0	75.7	78.2	81.3	81.3
Non-current Liabilities	295.8	354.9	368.4	343.8	343.8
+ Borrowings — Current	401.8	287.1	328.2	318.0	318.0
+ Trade Payables	480.3	425.5	416.1	477.9	477.9
+ Other Current Financial Liab	2.0	27.3	21.4	23.8	23.8
Current Financial Liabilities	884.1	739.9	765.8	819.6	819.6
+ Provisions — Current	4.4	3.0	4.3	8.1	8.1
+ Current Tax Liabilities	—	1.2	0.0	7.2	7.2
+ Other Current Liabilities	44.5	51.6	66.9	87.4	87.4
Current Liabilities	933.0	795.5	837.0	922.3	922.3
Total Liabilities	1,228.7	1,150.4	1,205.3	1,266.0	1,266.0
Total Equity & Liabilities	2,421.4	2,432.4	2,574.7	2,815.3	2,815.3
Assets — additional as-filed lines
+ Current Tax Assets	—	—	10.0	0.0	0.0
Trade Payables — MSME split
+ Dues to Micro & Small — Current	—	—	11.8	24.1	24.1
+ Dues to Other Creditors — Current	—	—	404.3	453.8	453.8

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.